Α-Acetyldigoxin
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 90%(Oral) |
Protein binding | 20–30% |
Elimination half-life | 40h |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.024.414 |
Chemical and physical data | |
Formula | C43H66O15 |
Molar mass | 822.986 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
α-Acetyldigoxin is a cardiac glycoside. It is an acetyl derivative of digoxin and an isomer of β-acetyldigoxin. It increases the contractility of the heart by its positive inotropic effect on cardiac muscle. The effects of α-acetyldigoxin begin 3–4 hours after administration, and maximize after 6–8 hours. It is prescribed for congestive chronic cardiac failure class II, III and IV.
External links
- α-acetyldigoxin in the ChemIDplus database
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.